Nucleic acid and corresponding protein entitled 161P2F10B...

Details Nucleic acid and corresponding protein entitled 161P2F10B... Nucleic acid and corresponding protein entitled 161P2F10B...

2007-06-05

2007-06-05

Siew, Jeffrey (Department: 1642)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C514S002600, C530S350000, C530S387100

Reexamination Certificate

active

10291241

ABSTRACT:
A novel gene 0161P2F10B (also designated 161P2F10B) and its encoded protein, and variants thereof, are described wherein 161P2F10B exhibits tissue specific expression in normal adult tissue, and is aberranty expressed in the cancers listed in Table I. Consequently, 161P2F10B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 161P2F10B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 161P2F10B can be used in active or passive immunization.

REFERENCES:
patent: 5001225 (1991-03-01), Taylor
patent: 6323321 (2001-11-01), Bühring
patent: 6342219 (2002-01-01), Thorpe et al.
patent: 2003/0165505 (2003-09-01), Challita-Eid et al.
patent: 2005/0265921 (2005-12-01), Challita-Eid et al.
patent: 2005/0265924 (2005-12-01), Challita-Eid et al.
patent: WO9960164 (1999-11-01), None
patent: WO200021990 (2000-04-01), None
patent: WO200157272 (2001-08-01), None
patent: WO200157273 (2001-08-01), None
patent: WO200157274 (2001-08-01), None
patent: WO200157275 (2001-08-01), None
patent: WO200157276 (2001-08-01), None
patent: WO200157277 (2001-08-01), None
patent: WO200157278 (2001-08-01), None
patent: WO200160860 (2001-08-01), None
patent: WO200175067 (2001-10-01), None
patent: WO200186003 (2001-11-01), None
patent: WO200279411 (2002-10-01), None
patent: WO2003004514 (2003-01-01), None
patent: WO2003016475 (2003-02-01), None
patent: WO2003040340 (2003-05-01), None
Colbern et al (J Inorg Biocehm, 1999, 77:117-120).
Houghton and Scheinberg (Seminars in Oncology, 1986, 13:165-179).
Bühring et al., Blood 94(7):2343-2356 (1999).
Bühring et al., Blood 97(10):3303-3305 (2001).
Burgess et al., Journal of Cell Biology 111:2129-2138 (1990).
Coleman, Research in Immunology 145:33-36 (1994).
Jin-Hua et al., Genomics 45(2):412-415 (1997).
Lazar et al., Molecular and Cellular Biology 8(3):1247-1252 (1988).
Lederman et al., Molecular Immunology 28:1171-1181 (1991).
Li et al., Proc Natl Acad Sci USA 77:3211-3214 (1980).
Paul (Ed.), Fundamental Immunology, 3rd ed., p. 242, 1993.
Reiger et al., Glossary of Genetics and Cytogenetics, Classical and Molecular, 4th Ed., Springer-Verlag, Berlin (1976).
Schwartz et al., Proc Natl Acad Sci USA 84:6408-6411 (1987).
Deissler et al., Journal of Biological Chemistry (1995) 270(17):9849-9855.
International Search Report for PCT/US02/36002, mailed on Jan. 5, 2005, 5 pages.

Affiliated with

Also associated with

Rating

Nucleic acid and corresponding protein entitled 161P2F10B... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid and corresponding protein entitled 161P2F10B..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 161P2F10B... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3866634